Resource Center

A new report from UPMC’s Center for Connected Medicine and KLAS Research about the AI use cases that health systems are prioritizing over the next few years includes findings about plans for radiology AI that raise two important questions for neuroradiologists and healthcare leaders: Based on a survey of 58 executives and senior managers at… “Health system priorities for AI and two important questions for radiology leaders”

Radiologists, neurologists, Alzheimer’s patients and their families are rightfully encouraged by the range of new drugs in development to slow or reduce cognitive decline. At the start of 2023 there were 187 trials for 141 drugs addressing Alzheimer’s pathologies. Two drugs, aducanumab and lecanemab, have received accelerated FDA approval in the past two years. A… “STAGE and the Promise and Challenges of New Alzheimer’s Drug Therapies”

There have been a growing number of efforts to improve the balance between MRI speed and image quality while addressing priority concerns about radiologist burnout, staffing shortages, health system financial stability and the clinical needs of an aging population. Methods including mobile dockable exam tables, redesigned MRI suites, and AI-based image reconstruction have shown the… “To Improve MRI Speed, Quality and Efficiency, Start at the Source”

Improving MRI efficiency to improve access to advanced imaging, provider and patient experiences, and health system revenues has been a long-standing goal for radiologists and health system administrators. That’s been true long before the development of radiology AI models for workflow orchestration, task automation and augmented diagnosis. Radiologists have used a variety of practical and… “Clarity, Speed and Confidence vs. “Widgets”: The key to MRI efficiency”

A view from the front lines at a community health system, with Dr. James Backstrom.

While there’s no doubt that AI-based solutions can play a valuable role in diagnostic imaging, many of the radiology and health system leaders we spoke with at the 2022 RSNA conference were are asking an important question: are today’s AI models the right solutions for improving MRI efficiency? We heard that and similar questions especially… “Improving MRI Efficiency Begins With Asking The Right Questions”

To understand the significance of the SpinTech MRI STAGE software platform, it helps to begin by asking a question: Given that MRI is an incredibly powerful diagnostic tool for neurological diseases like Alzheimer’s, dementia, Parkinson’s and multiple sclerosis (MS), why have radiologists and neurologists had to choose between conducting faster MRI exams and obtaining higher-quality… “Do you really have to sacrifice MRI image quality for speed?”

SpinTech MRI to Expand Deployment of STAGE™ Software to Speed Diagnosis and Treatment of Brain Diseases with $6.5 Million in Series A Financing, Led by Level 8 Ventures and Genesis Innovation Group’s Cultivate(MD) Capital Fund

So….You want to shorten the time of your MRI protocols, while also preserving the quality of the images? SpinTech MRI has the solution for you. The following abstract, led by members of Yale School of Medicine – Radiology and Biomedical Imaging, gives a structured overview of the concept of MRI acceleration, and the main approaches… “A Comparison of Time-Efficient MR Techniques and Critical Details to Consider”

The purpose of this study was to evaluate the effect of resolution on iron content using quantitative susceptibility mapping (QSM); to verify the consistency of QSM across field strengths and manufacturers in evaluating the iron content of deep gray matter…

The use of Quantitative Susceptibility Mapping (QSM) is often viewed as incompatible with current standard radiology workflows. Some radiologists or departments may be unaware of its existence or purpose. Despite the skepticism surrounding its viability in a clinical setting, QSM shows great potential in a wide range of clinical applications, particularly for biomarker detection and… “The Future of Quantitative Susceptibility Mapping (QSM) in Clinical Applications”

Ward Detwiler, our President and CEO, had the opportunity to speak about how STAGE is innovating the world of MR at MedTech Strategist Innovation 2021.